EP1351681 - IMPLANTABLE DEVICE CONTAINING RESORBABLE MATRIX MATERIAL AND ANTI-PROLIFERATIVE DRUGS FOR PREVENTING OR TREATING FAILURE OF HEMODIALYSIS VASCULAR ACCESS AND OTHER VASCULAR GRAFTS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.07.2011 Database last updated on 24.08.2024 | Most recent event Tooltip | 27.09.2013 | Lapse of the patent in a contracting state New state(s): TR | published on 30.10.2013 [2013/44] | Applicant(s) | For all designated states Vascular Therapies, LLC 201 East 87th Street, Apt. 14C New York, NY 10128 / US | [2003/42] | Inventor(s) | 01 /
IYER, Sriram, S. 201 East 87th Street, Apt. 14C New York, NY 10128 / US | 02 /
KIPSHIDZE, Nicholas, N. 345 E. 80th Street, Apt. 25B New York, NY 10021 / US | 03 /
NIKOLAYCHIK, Victor, V. 112 East Friestadt Street, Apt. F Mequon, WI 53092 / US | [2003/42] | Representative(s) | Watson, Robert James, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2003/42] | Watson, Robert James, et al Mewburn Ellis York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 02718844.0 | 16.01.2002 | [2003/42] | WO2002US01375 | Priority number, date | US20010262132P | 16.01.2001 Original published format: US 262132 P | [2003/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO02062335 | Date: | 15.08.2002 | Language: | EN | [2002/33] | Type: | A2 Application without search report | No.: | EP1351681 | Date: | 15.10.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2002 takes the place of the publication of the European patent application. | [2003/42] | Type: | B1 Patent specification | No.: | EP1351681 | Date: | 15.09.2010 | Language: | EN | [2010/37] | Search report(s) | International search report - published on: | EP | 27.12.2002 | Classification | IPC: | A61K31/395, A61K31/337, A61K38/13, A61K38/08, A61K31/727, A61K31/122, A61K31/573, A61K47/36, A61K47/42, A61P43/00 | [2003/42] | CPC: |
A61K31/436 (EP,US);
A61K31/122 (EP,US);
A61K31/337 (EP,US);
A61K31/395 (EP,US);
A61K31/573 (EP,US);
A61K31/727 (EP,US);
A61K9/0024 (EP,US);
A61L27/20 (US);
A61L27/225 (US);
A61L27/44 (US);
A61L27/54 (US);
A61L31/16 (EP,US);
A61M1/3655 (EP,US);
A61M39/0247 (EP,US);
A61P31/00 (EP);
A61P37/06 (EP);
A61P41/00 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P7/08 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
A61L2300/204 (US);
A61L2300/252 (US);
A61L2300/416 (EP,US);
A61M1/16 (EP,US);
A61M2039/0258 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/42] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | IMPLANTIERBARE VORRICHTUNG ENTHALTEND RESORBIERBARES MATRIXMATERIAL UND ANTIPROLIFERATIVE WIRKSTOFFE ZUR VORBEUGUNG ODER BEHANDLUNG VON VERSAGEN VASKULÄRER HÄMODIALYSEZUGÄNGE UND ANDERER VASKULÄRER TRANSPLANTATE | [2003/42] | English: | IMPLANTABLE DEVICE CONTAINING RESORBABLE MATRIX MATERIAL AND ANTI-PROLIFERATIVE DRUGS FOR PREVENTING OR TREATING FAILURE OF HEMODIALYSIS VASCULAR ACCESS AND OTHER VASCULAR GRAFTS | [2003/42] | French: | APPAREIL ET METHODES DE PREVENTION OU DE TRAITEMENT EN CAS D'ECHEC D'UN ACCES VASCULAIRE POUR HEMODIALYSE ET EN CAS DE REJET DE GREFFONS VASCULAIRES | [2003/42] | Entry into regional phase | 07.08.2003 | National basic fee paid | 07.08.2003 | Designation fee(s) paid | 07.08.2003 | Examination fee paid | Examination procedure | 05.08.2002 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 06.08.2003 | Amendment by applicant (claims and/or description) | 07.08.2003 | Examination requested [2003/42] | 12.03.2007 | Despatch of a communication from the examining division (Time limit: M04) | 23.07.2007 | Reply to a communication from the examining division | 26.10.2007 | Despatch of a communication from the examining division (Time limit: M04) | 05.03.2008 | Reply to a communication from the examining division | 18.09.2008 | Despatch of a communication from the examining division (Time limit: M06) | 24.03.2009 | Reply to a communication from the examining division | 26.11.2009 | Date of oral proceedings | 17.12.2009 | Date of oral proceedings | 05.02.2010 | Cancellation of oral proceeding that was planned for 12.02.2010 | 12.02.2010 | Date of oral proceedings (cancelled) | 08.03.2010 | Communication of intention to grant the patent | 19.07.2010 | Fee for grant paid | 19.07.2010 | Fee for publishing/printing paid | Divisional application(s) | EP10176383.7 / EP2314293 | EP17150201.6 | Opposition(s) | 16.06.2011 | No opposition filed within time limit [2011/34] | Fees paid | Renewal fee | 26.01.2004 | Renewal fee patent year 03 | 20.01.2005 | Renewal fee patent year 04 | 25.01.2006 | Renewal fee patent year 05 | 29.01.2007 | Renewal fee patent year 06 | 25.01.2008 | Renewal fee patent year 07 | 30.01.2009 | Renewal fee patent year 08 | 25.01.2010 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 15.09.2010 | BE | 15.09.2010 | CY | 15.09.2010 | DK | 15.09.2010 | FI | 15.09.2010 | IT | 15.09.2010 | NL | 15.09.2010 | SE | 15.09.2010 | TR | 15.09.2010 | GR | 16.12.2010 | ES | 26.12.2010 | IE | 16.01.2011 | LU | 16.01.2011 | PT | 17.01.2011 | CH | 31.01.2011 | LI | 31.01.2011 | MC | 31.01.2011 | [2013/44] |
Former [2013/25] | AT | 15.09.2010 | |
BE | 15.09.2010 | ||
CY | 15.09.2010 | ||
DK | 15.09.2010 | ||
FI | 15.09.2010 | ||
IT | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
ES | 26.12.2010 | ||
IE | 16.01.2011 | ||
LU | 16.01.2011 | ||
PT | 17.01.2011 | ||
CH | 31.01.2011 | ||
LI | 31.01.2011 | ||
MC | 31.01.2011 | ||
Former [2012/08] | AT | 15.09.2010 | |
BE | 15.09.2010 | ||
CY | 15.09.2010 | ||
DK | 15.09.2010 | ||
FI | 15.09.2010 | ||
IT | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
ES | 26.12.2010 | ||
IE | 16.01.2011 | ||
PT | 17.01.2011 | ||
CH | 31.01.2011 | ||
LI | 31.01.2011 | ||
MC | 31.01.2011 | ||
Former [2011/48] | AT | 15.09.2010 | |
BE | 15.09.2010 | ||
CY | 15.09.2010 | ||
DK | 15.09.2010 | ||
FI | 15.09.2010 | ||
IT | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
ES | 26.12.2010 | ||
PT | 17.01.2011 | ||
CH | 31.01.2011 | ||
LI | 31.01.2011 | ||
MC | 31.01.2011 | ||
Former [2011/40] | AT | 15.09.2010 | |
BE | 15.09.2010 | ||
CY | 15.09.2010 | ||
DK | 15.09.2010 | ||
FI | 15.09.2010 | ||
IT | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
ES | 26.12.2010 | ||
PT | 17.01.2011 | ||
MC | 31.01.2011 | ||
Former [2011/31] | AT | 15.09.2010 | |
BE | 15.09.2010 | ||
CY | 15.09.2010 | ||
FI | 15.09.2010 | ||
IT | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
ES | 26.12.2010 | ||
PT | 17.01.2011 | ||
Former [2011/24] | AT | 15.09.2010 | |
CY | 15.09.2010 | ||
FI | 15.09.2010 | ||
NL | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
PT | 17.01.2011 | ||
Former [2011/15] | AT | 15.09.2010 | |
CY | 15.09.2010 | ||
FI | 15.09.2010 | ||
SE | 15.09.2010 | ||
GR | 16.12.2010 | ||
Former [2011/13] | AT | 15.09.2010 | |
CY | 15.09.2010 | ||
FI | 15.09.2010 | ||
Former [2011/10] | AT | 15.09.2010 | |
FI | 15.09.2010 | ||
Former [2011/08] | AT | 15.09.2010 | Cited in | International search | [X]WO9323013 (NEW ENGLAND DEACONESS HOSPITAL [US]) [X] 2-9,11,15-19,21-31 * page 1, lines 15-21 * * page 5, line 25 - page 6, line 2 * * page 14, line 28 - page 15, line 2 *; | [X]US5486524 (FAILLI AMEDEO A [US], et al) [X] 2-9,11,15-19,21-31 * column 1, lines 63-66 * * column 10, line 20 *; | [X]US5527532 (EDELMAN ELAZER R [US], et al) [X] 2-9,11,15-19,21-31 * column 3, lines 48-54 * * column 4, lines 41-44 * * column 4, line 56 - column 5, line 6 * * column 5, lines 16-22 * * column 4, lines 32-38 *; | [X]US5766584 (EDELMAN ELAZER R [US], et al) [X] 2-9,11,15-19,21-31 * column 2, line 41 * * column 3, line 6 * * column 3, line 62 * * column 4, line 2 * * column 2, lines 54-62 * * column 4, lines 30,31,44,45,54 *; | [X]US6328762 (ANDERSON DIANE LEE [US], et al) [X] 2-9,11,15-19,21-31 * column 3, lines 39-48; claim 23 * * column 2, line 63 - column 3, line 2 * * column 3, lines 7-11 *; | [E]WO0236054 (SIROLIMED LLC [US]) [E] 2-9,11,15-19,21-31 * page 2, lines 7-9,16,17 * * page 3, line 20 ** page 9, lines 17-19 *; | [X] - EDELMAN^A E R ET AL, "Perivascular graft heparin delivery using biodegradable polymer wraps", BIOMATERIALS, ELSEVIER SCIENCE PUBLISHERS BV., BARKING, GB, (20001115), vol. 21, no. 22, ISSN 0142-9612, pages 2279 - 2286, XP004210285 [X] 2-9,11,15-19,21-31 * page 2280, column 1, paragraph L * * page 2283, column 2, paragraph L - page 2284, column 1, paragraph 1 * DOI: http://dx.doi.org/10.1016/S0142-9612(00)00154-X | [X] - HIRIGOYEN M B ET AL, "Periadventitial delivery of heparin in the prevention of microvenous thrombosis.", JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY: OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS. UNITED STATES SEP 1996, (199609), vol. 54, no. 9, ISSN 0278-2391, pages 1097 - 1102, XP001097380 [X] 2-9,11,15-19,21-31 * p.1097 "Purpose" * * page 1099; figure 3 * DOI: http://dx.doi.org/10.1016/S0278-2391(96)90169-X | by applicant | US4164559 | US4409332 | US6162247 | US6206931 | US6323184 | - PRICE, P. ET AL., "Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves", ATHEROSCLER THROMB VASC BIOL, (1998), vol. 18, pages 1400 - 1407, XP000960945 | - HERMANN, S.M. ET AL., "Polymorphisms of the human matrix Gla-protein gene (MGP) vascular calcification and myocardial infarction", ARTERIOSCLER THROMB VASE BIOL., (2000), vol. 20, pages 2836 - 2893 | - PRICE P. ET AL., "Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves", ATHEROSCLER THROMB. VASC. BIOL., (1998), vol. 18, pages 1400 - 1407, XP000960945 | - HERMANN S.M. ET AL., "Polymorphisms of the human matrix Gla-protein gene (MGP) vascular calcification and myocardial infarction", ARTERIOSCLER THROMB. VASC. BIOL., (2000), vol. 20, pages 2836 - 93 | - ALMIN, C.; CHUNLIN, H.; JULIANG, B. ET AL., "Antibiotic loaded chitosan bar. In vitro, in vivo study of a possible treatment for osteomyelitis", CLIN ORTHOL2, (199909), pages 239 - 247, XP009038846 | - YAO L; MIZUSHIGE K; MURAKAMI K ET AL., "Troglitozone decreases collagen accumulation in prediabetic stage of a type II diabetic rat model", HEART, (2000), vol. 84, pages 209 - 210 | - NAKANO M; NAKAYAMA Y; KOHDA A ET AL., "Acute subcutaneous toxicity of SM-10500 in rats", KISOTO RINSHO, (1995), vol. 29, pages 1675 - 1699 | - FERRON GM; CONWAY WD; JUSKO WJ., "Lipophilic benzamide and anilide derivatives as high-performance liquid chromatography internal standard: application to sirolimus (rapamycin) determination", J CHROMATOGR B BIOMED SCI APPL, (199712), vol. 703, doi:doi:10.1016/S0378-4347(97)00415-5, pages 243 - 251, XP004100040 DOI: http://dx.doi.org/10.1016/S0378-4347(97)00415-5 | - WACHOL-DREWEK Z; PFEIFER M; SCHOLL E., "Comparative investigation of drug delivery of collagen implants saturated in antibiotic solutions and sponge containing gentamicin", BIOMATERIALS, (1996), vol. 17, doi:doi:10.1016/0142-9612(96)87654-X, pages 1733 - 1738, XP004032983 DOI: http://dx.doi.org/10.1016/0142-9612(96)87654-X | - MEHTA S; HUMPHREY JS; SCHENKMAN DI ET AL., "Gentamycin distribution from a collagen carrier", J ORTHOP. RES., (1996), vol. 14, doi:doi:10.1002/jor.1100140511, pages 749 - 754, XP055118622 DOI: http://dx.doi.org/10.1002/jor.1100140511 |